Options
Methods and criteria for validating the multimodal functions of perinatal derivatives when used in oncological and antimicrobial applications
Date Issued
2022-10-13
Date Available
2024-05-07T10:10:53Z
Abstract
Perinatal derivatives or PnDs refer to tissues, cells and secretomes from perinatal, or birth-associated tissues. In the past 2 decades PnDs have been highly investigated for their multimodal mechanisms of action that have been exploited in various disease settings, including in different cancers and infections. Indeed, there is growing evidence that PnDs possess anticancer and antimicrobial activities, but an urgent issue that needs to be addressed is the reproducible evaluation of efficacy, both in vitro and in vivo. Herein we present the most commonly used functional assays for the assessment of antitumor and antimicrobial properties of PnDs, and we discuss their advantages and disadvantages in assessing the functionality. This review is part of a quadrinomial series on functional assays for the validation of PnDs spanning biological functions such as immunomodulation, anticancer and antimicrobial, wound healing, and regeneration.
Other Sponsorship
European Cooperation in Science and Technology
French Ministry of Health
Slovenian Research Agency
Italian Ministry of Research and University
Fondazione Alessandra Bono Onlus
Type of Material
Journal Article
Publisher
Frontiers Media
Journal
Frontiers in Bioengineering and Biotechnology
Volume
10
Start Page
1
End Page
15
Copyright (Published Version)
2022 The Authors
Language
English
Status of Item
Peer reviewed
ISSN
2296-4185
This item is made available under a Creative Commons License
File(s)
Loading...
Name
fbioe-10-958669 2022 Fct Assays Part B.pdf
Size
764.92 KB
Format
Adobe PDF
Checksum (MD5)
48af44340c069b8bb8717e3b5729738e
Owning collection
Mapped collections